Hydrogen Therapy Shows Promise for Severe Lung Injury Treatment

Scientists found that molecular hydrogen (a simple gas) might help protect people's lungs when they get seriously sick with conditions like severe COVID-19, because it can reduce inflammation and damage in lung tissue. This could be a new way to treat patients who are struggling to breathe, but doctors need to do more real-world testing to make sure it actually works.

Molecular hydrogen may protect against acute lung injury through anti-inflammatory, antioxidant, and cell-regulating mechanisms, though clinical evidence in humans remains limited.

This review article examined how molecular hydrogen might help treat acute lung injury (ALI), a serious breathing condition that occurs in critically ill patients. The authors looked at existing research showing that hydrogen may reduce inflammation (swelling), fight harmful molecules called oxidants, and affect how cells die and clean themselves. They concluded that hydrogen shows promise as a potential treatment for ALI and severe respiratory problems, especially those caused by COVID-19, but noted that more clinical studies in humans are needed to prove it works.

While this review suggests hydrogen therapy could be a promising approach for severe lung injury, it is important to note this is a summary of existing research, not a new study with human data. The authors themselves call for further clinical trials to determine whether hydrogen actually works in patients with lung disease. Anyone with acute respiratory illness should follow their doctor's current treatment recommendations rather than relying on hydrogen therapy at this stage.

Acute lung injury (ALI) and acute respiratory distress syndrome, which is a more severe form of ALI, are life-threatening clinical syndromes observed in critically ill patients. Treatment methods to alleviate the pathogenesis of ALI have improved to a great extent at present. Although the efficacy…

Read the full abstract on PubMed